Company intelligence / Profile preview

OBS

Ownership: Private
Development stage: Commercial

Overview

Obsurge Biotech Ltd. is an established Indian pharmaceutical company founded in 2002. It manufactures and markets a wide range of allopathic medicines with a focus on affordable pricing for diverse patient segments. The company has built strong brands such as SERADIC, Anxiset, and DUB Range that are leaders in their respective segments. Products are available both domestically across India and exported to Southeast Asia and the Middle East. The company holds ISO 9001:2008 certification for quality management.

Therapeutic areas: OtherPsychiatryDermatologyGastroenterologyCardiovascularOphthalmologyNeurologyWomen's Health
Modalities: Small moleculeGeneric drugs
Industry: Biotech

Beyond the preview

Go deeper on OBS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OBS.

Explore the full profile